Cigna/Express Scripts cleared: The Tipline for 18 September 2018
One of the two pending vertical healthcare mergers is cleared to go ahead, after the Department of Justice’s antitrust division allowed the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act to expire for insurer Cigna’s $52 billion merger with pharmacy benefit manager Express Scripts. We also have stories on the latest in the Androgel litigation and two new additions at the Antitrust Division.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10